144 results
Page 2 of 8
8-K
EX-99.1
1v4ksjn
23 Dec 22
Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement
4:11pm
425
5uefsr 2w5ber9eb
14 Dec 22
Business combination disclosure
9:56pm
8-K
bd253ao4 uo
14 Dec 22
Other Events
9:49pm
425
owe l7x65
6 Dec 22
Business combination disclosure
7:02am
8-K
hixhvdq folejfp
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
EX-99.2
anybtf ldn
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
8-K
EX-99.1
hy7jy
6 Dec 22
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
7:00am
425
byyjp345ye84z5rqj
14 Nov 22
Business combination disclosure
4:20pm
8-K
EX-99.1
lzfb7ajymg ib7j835
14 Nov 22
Equillium Reports Third Quarter 2022 Financial Results and Provides Corporate and Clinical Updates
4:10pm
424B3
3s5f3d6um ltk
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
hksageojoq8vdc38 o2f
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
uj0rhx
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
r12d l5ddapbv
27 Sep 22
Business combination disclosure
9:30am
8-K
EX-99.1
2rodtprysbw9v4xyo
27 Sep 22
Other Events
9:28am
8-K
euzgq m81ypov6v
27 Sep 22
Other Events
9:28am
425
yyx8d5z1d8f8v rw
26 Sep 22
Business combination disclosure
5:29pm
8-K
EX-99.3
kiwvc4noemy4h6750
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
8-K
EX-99.2
tmvzs65ondn0
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
425
wyyt6l
7 Sep 22
Business combination disclosure
5:00pm